Pres, CFO at Alto Neuroscience, Inc. Sells $3.57 million in Stock

Nicholas Conrad Smith, who serves as Pres, CFO at Alto Neuroscience, Inc. (ANRO), sold 134,886 shares of the company's stock, according to a disclosure filed with the U.S. Securities and Exchange Commission.

The transaction was executed at a price of $26.45 per share, for a total value of approximately $3.57 million.

Insider transactions of this kind are publicly disclosed through Form 4 filings with the SEC, which must generally be submitted within two business days of the trade date.

Sales by insiders often reflect routine portfolio management or pre-scheduled trading plans rather than a view on the company's prospects.